- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05045170
Sedation and Memory Consolidation
The Influence of Propofol and Dexmedetomidine Sedation on Memory Consolidation
Study Overview
Status
Conditions
Detailed Description
The study is a prospective, randomized, single blind design. Patients undergoing elective trauma surgery (arthroscopy, reconstructive foot surgery) under subarachnoidal anesthesia are enrolled in this study. All patients were randomly divided into three groups depending on the drug type: first - propofol, second - dexmedetomidine, third - control.
The Montreal cognitive assessment test (MoCA - test) is a high validity test. MoCA - test is used to determine cognitive impairments in patients in the pre-operative period. The MoCA test time is approximately 10 minutes. The maximum possible score is 30; 26 points and more are considered normal, 25 or less is evidence of cognitive impairment.
American Society of Anesthesiologists (ASA) physical status classification system is used to assess and communicate a patient's pre-anesthesia medical co-morbidities (ASA I - a normal healthy patient, ASA II - a patient with mild systemic disease, ASA III - a patient with severe systemic disease, ASA IV - a patient with severe systemic disease that is a constant threat to life, ASA V - a moribund patient who is not expected to survive without the operation, ASA VI - a declared brain-dead patient whose organs are being removed for donor purposes.
To determine the level of anxiety and depression in the preoperative period, patients are tested using the Hospital Anxiety and Depression Scale (HADS). Values on the HADS scale<7 points are interpreted as normal, with scores from 8 to 10 as subclinically expressed anxiety and/or depression, and above 10 points-clinically expressed anxiety and/or depression.
In the operating room intravenous (i.v.) peripheral canulla Vasofix Certo (B. Braun, Germany) with a diameter of 18 or 20 Gauge is inserted before the start of regional anesthesia for infusion therapy. Before spinal anesthesia an anesthesiologist inject 0.9% saline infusion (Grotex, Russia) of 6-8 ml/kg.
Following this procedure, the investigators perform a puncture of the subarachnoid space with a 27 Gauge Pencil Point needle (Bbraun, Germany) under aseptic conditions under local anesthesia with lidocaine (Pharmasyntez, Russia) at the L2-L4 level. The criterion for verifying the subarachnoid space is the appearance of liquor in the needle pavilion. After performing the aspiration test, 10-15 mg of an isobaric solution of moxicaine (Novosibhimfarm, Russia) is injected. To evaluate the sensory block, the investigators use the tactile sensitivity loss test ('pinprick' test), and the motor block-the Bromage test.
0.9% saline (20 - 25 ml/kg) is administered to patients in the all groups. Propofol (1 group (Propofol Kabi, Registration number from the State Register of Medicines - 000875)) or dexmedetomidine (2 group (Dexmedetomidine, Registration number from the State Register of Medicines - 005916) are used for sedation. Intravenous infusion of propofol or dexmedetomidine is performed with a BBraun Space (B. Braun Melsungen AG, Registration certificate for a medical device RZN 2013/905). Target control infusion (TCI, Shnider model) is applied for the dosing of propofol concentration. At the beginning of sedation, the level of the target propofol concentration is 1.5 - 2 mcg ml-1, during operation - 2.5 mcg ml-1. Intravenous infusion of dexmedetomidine starts with a dose of 1 mcg/kg for 10 minutes, with maintaining dose from 0.6 to 0.7 mcg/kg/min follows by titration from 0.2 to 2 mcg/kg/h depending on the level of sedation. Propofol or dexmedetomidine infusion terminates 10 minutes before the end of the operation. 0.9% saline (20 - 25 ml/kg) is administered to patients in the control group (3 group). Sedation is not performed in control group.
The Richmond agitation and sedation Scale (RASS) and bispectral index monitor A-2000XP (BIS, Aspect Medical Systems, Inc. (USA), Registration certificate for a medical device RZN 2005/498) are used to assess the depth of sedation. RASS values '-2' - '-3' (short-term eyes opening for less than 10 seconds or voluntary movements without eye contact in response to a call) correspond to light-moderate sedation, '-4' (eyes opening or voluntary movements in response to physical stimulation) - deep sedation. BIS values 70 - 90 correspond to light - moderate sedation, 60 - 70 - deep sedation.
To ensure patient safety, the investigators use the basic monitoring standard: noninvasive arterial pressure (NAP), heart rate (HR), electrocardiogram (ECG), SpO2, capnography (Philips Monitor IntelliVue MP40 (Medizin Systeme Boblingen GmbH, Germany, Registration certificate for a medical device RZN 2014/2009)).
Memory testing is conducted in three stages. Stage 1 - immediately prior to sedation, stage 2 - 5-10 minutes after the start of sedation (RASS '-1' - '-2', BIS 70 - 90), stage 3 - 10 minutes after sedation is finished and consciousness is restored (RASS '0', BIS 95 - 100). Five emotionally neutral words are heard by the patients twice at each stage to assess the impact of sedation on memory consolidation. The experimental words are different at each stage. The patients repeat the memorized words after each audition. To assess the effect of sedation on the 'working memory', anesthesiologist asked the patient to remember and reproduce the memorized words five minutes after learning in the second stage. Approximately, 24 hours after the end of anesthesia, recall and recognition of the experimental words are tested. To assess recall, the patients remember all the words listened before, during and after anesthesia. To test recognition, patients use to mark the words learned during surgery in the list of words, which consists of 15 experimental and 10 control. The number of words in recall and recognition testing is recorded by researcher.
Statistical analysis is perfomed in MS Excel and Jamovi 2.0.0 programs. The Shapiro-Wilk and Kolmogorov-Smirnov tests are used to determine the normality of the distribution. The analysis of the categorical variables is evaluated using the criterion χ2. For inter-group comparison of quantitative variables, one-way analysis of variance (one-way ANOVA) followed by post-hoc Bonferroni test are used. Repeated measures analysis of variance (RM-ANOVA) followed by post hoc tests for multiple comparisons, which are Bonferroni-adjusted, are performed to compare data within groups. Statistical significance level is set at P < 0.05.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Moscow, Russian Federation
- City Clinical Hospital № 31 of the Department of Health of Moscow
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Written informed consent
- Age ≥ 18 and ≤70 years
- Elective trauma surgery (arthroscopy, reconstructive foot surgery) under regional anesthesia (spinal anesthesia) with propofol, dexmedetomidine or without sedation
- Montreal cognitive assessment test ≥ 26
- Patients with American Society of Anesthesiologists (ASA) I-II
Non-inclusion criteria:
- Not written informed consent to participate in the research and/or perform regional blockade
- Age˂18 and ˃70 years
- Allergy to propofol, dexmedetomidine, lidocaine, bupivacaine
- Pregnancy
- Epilepsy anamnesis
- II-III degree atrioventricular block
- Montreal cognitive assessment test ˂ 26
- Patients with American Society of Anesthesiologists (ASA) ˃ II
- Emergency operation
- The presence of psychiatric disorders
- Сancer patients with a life expectancy of less than two years
- Taking anticoagulants, psychotropic drugs
Exclusion Criteria:
- Patient refuse from further participation
- Ineffective spinal anesthesia
- Allergy on anesthesia drugs during perioperative period
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: propofol group
patients with American Society of Anesthesiologists (ASA) I-II, Montreal cognitive assessment test≥26, trauma surgery under spinal anesthesia with propofol sedation
|
Spinal anesthesia is performed by anesthesiologist.
Memory testing is conducted immediately prior to propofol sedation (stage 1), 5-10 minutes after the start of propofol sedation (stage 2), 10 minutes after propofol sedation is finished and consciousness is restored (stage 3).
Five emotionally neutral words are heard by the patients twice at each stage to assess the impact of sedation on memory consolidation.
The patients repeat the memorized words after each audition.
To assess the effect of sedation on the 'working memory', anesthesiologist asked the patient to remember and reproduce the memorized words five minutes after learning in the second stage.
Approximately, 24 hours after the end of anesthesia, recall and recognition of the experimental words are tested.
The number of words in recall and recognition testing is recorded by researcher.
|
Experimental: dexmedetomidine group
patients with American Society of Anesthesiologists (ASA) I-II, Montreal cognitive assessment test≥26, trauma surgery under spinal anesthesia with dexmedetomidine sedation
|
Spinal anesthesia is performed by anesthesiologist.
Memory testing is conducted immediately prior to dexmedetomidine sedation (stage 1), 5-10 minutes after the start of dexmedetomidine sedation (stage 2), 10 minutes after dexmedetomidine sedation is finished and consciousness is restored (stage 3).
Five emotionally neutral words are heard by the patients twice at each stage to assess the impact of sedation on memory consolidation.
The patients repeat the memorized words after each audition.
To assess the effect of sedation on the 'working memory', anesthesiologist asked the patient to remember and reproduce the memorized words five minutes after learning in the second stage.
Approximately, 24 hours after the end of anesthesia, recall and recognition of the experimental words are tested.
The number of words in recall and recognition testing is recorded by researcher.
|
Placebo Comparator: control group
patients with American Society of Anesthesiologists (ASA) I-II, Montreal cognitive assessment test≥26, trauma surgery under spinal anesthesia without sedation
|
Spinal anesthesia is performed by anesthesiologist.
Memory testing is conducted immediately prior to operation (stage 1), 5-10 minutes after the start of operation (stage 2), 10 minutes before the end of operation (stage 3).
Five emotionally neutral words are heard by the patients twice at each stage to assess the impact of sedation on memory consolidation.
The patients repeat the memorized words after each audition.
To assess the effect of sedation on the 'working memory', anesthesiologist asked the patient to remember and reproduce the memorized words five minutes after learning in the second stage.
Approximately, 24 hours after the end of anesthesia, recall and recognition of the experimental words are tested.
The number of words in recall and recognition testing is recorded by researcher.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
memory consolidation impairment with propofol sedation
Time Frame: 24 hours after the end of anesthesia
|
Memorizing emotionally neutral words before, during and after propofol sedation.
Evaluation of recall and recognition of words 24 hours after anesthesia.
|
24 hours after the end of anesthesia
|
memory consolidation impairment with dexmedetomidine sedation
Time Frame: 24 hours after the end of anesthesia
|
: Memorizing emotionally neutral words before, during and after dexmedetomidine sedation.
Evaluation of recall and recognition of words 24 hours after anesthesia.
|
24 hours after the end of anesthesia
|
memory consolidation impairment without sedation
Time Frame: 24 hours after the end of anesthesia
|
Memorizing emotionally neutral words before, during and after operation.
Evaluation of recall and recognition of words 24 hours after anesthesia.
|
24 hours after the end of anesthesia
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
'working memory' impairment with propofol sedation
Time Frame: 5 minutes after memorizing emotionally neutral words during propofol sedation
|
Memorizing emotionally neutral words during propofol sedation (stage 2).
Evaluation of remembering and reproducing of words five minutes after learning.
|
5 minutes after memorizing emotionally neutral words during propofol sedation
|
'working memory' impairment with dexmedetomidine sedation
Time Frame: 5 minutes after memorizing emotionally neutral words during dexmedetomidine sedation
|
Memorizing emotionally neutral words during dexmedetomidine sedation (stage 2).
Evaluation of remembering and reproducing of words five minutes after learning.
|
5 minutes after memorizing emotionally neutral words during dexmedetomidine sedation
|
'working memory' impairment without sedation
Time Frame: 5 minutes after memorizing emotionally neutral words during operation
|
Memorizing emotionally neutral words during operation (stage 2).
Evaluation of remembering and reproducing of words five minutes after learning.
|
5 minutes after memorizing emotionally neutral words during operation
|
Collaborators and Investigators
Investigators
- Principal Investigator: Vyacheslav Churakov, PgS, I.M. Sechenov First Moscow State Medical University (Sechenov University)
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Mental Disorders
- Nervous System Diseases
- Neurologic Manifestations
- Neurobehavioral Manifestations
- Neurocognitive Disorders
- Memory Disorders
- Amnesia
- Physiological Effects of Drugs
- Adrenergic Agents
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Anesthetics, Intravenous
- Anesthetics, General
- Anesthetics
- Analgesics, Non-Narcotic
- Adrenergic alpha-2 Receptor Agonists
- Adrenergic alpha-Agonists
- Adrenergic Agonists
- Hypnotics and Sedatives
- Propofol
- Dexmedetomidine
Other Study ID Numbers
- 2107
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Sharing Time Frame
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Memory Impairment
-
David Merrill, MD, PhDCompletedMemory ImpairmentUnited States
-
Neurolgy Institute for Brain Health and FitnessDSM Nutritional Products, Inc.UnknownMemory ImpairmentUnited States
-
University of California, San FranciscoFederal University of Minas GeraisCompleted
-
Porter Adventist HospitalTerminated
-
Stanford UniversityNational Institutes of Health (NIH); National Institute on Aging (NIA)Completed
-
University of ManitobaUnknown
-
University of ManitobaUnknownMemory Impairment
-
University of Texas Southwestern Medical CenterNational Institute on Drug Abuse (NIDA)Completed
-
AstraZenecaCompletedHealthy | Memory ImpairmentUnited States
Clinical Trials on Influence of propofol sedation on memory consolidation and 'working memory'
-
Cooperative International Neuromuscular Research...CompletedMuscular Dystrophy, DuchenneUnited States
-
German Parkinson Study Group (GPS)Philipps University Marburg Medical Center; MSE Pharmazeutika GmbH, Louisenstr... and other collaboratorsCompletedProgressive Supranuclear PalsyGermany
-
Mclean HospitalNational Alliance for Research on Schizophrenia and DepressionCompleted
-
IRCCS Fondazione Stella MarisUniversity of Pisa; University of MilanCompletedPeriventricular LeukomalaciaItaly
-
Memorial Sloan Kettering Cancer CenterCompletedPediatric Pateints | Amnesic Properties of PropofolUnited States
-
Selcuk UniversityCompletedBirth, First | Labor Long | Apgar; 4-7 at 1 Minute | Birth Outcome, AdverseTurkey
-
Université Catholique de LouvainCliniques universitaires Saint-Luc- Université Catholique de LouvainNot yet recruitingPost-operative PainBelgium
-
Sun Yat-sen UniversityCompleted
-
University of California, Los AngelesUnknownTraumatic Brain InjuryUnited States
-
Weill Medical College of Cornell UniversityNational Institute of Neurological Disorders and Stroke (NINDS); University...Terminated